The Pharmacy Times® Digestive Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health of the digestive system, including Crohn disease, inflammatory bowel disease, irritable bowel syndrome, and ulcerative colitis.
April 15th 2024
There was no difference observed between adalimumab (Humira; AbbVie) and adalimumab-aacf (Idacio; Fresenius Kabi) for those who switched to the biosimilar.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Improving Knowledge, Access, and Utilization of Biosimilars for Inflammatory Bowel Disease
1.0 Credit / Gastroenterology
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
1.0 Credit / Gastroenterology
View More
The Evolving Treatment Landscape of Acid-Related Disorders: The Role of New and Emerging Potassium-Competitive Acid Blocker Therapies (Pharmacy Technician Credit)
2.0 Credits / H Pylori
View More
The Evolving Treatment Landscape of Acid-Related Disorders: The Role of New and Emerging Potassium-Competitive Acid Blocker Therapies (Pharmacist Credit)
2.0 Credits / H Pylori
View More
Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis
1.5 Credits / Gastroenterology, Immunology
View More
Clinical Management of Short Bowel Syndrome: Pharmacist-Led Strategies in Patient Care
1.5 Credits / Gastroenterology
View More
Understanding the Burden of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis
1.0 Credit / Gastroenterology, Immunology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies
1.0 Credits / Gastroenterology, Immunology
View More
Study: Ultra-Processed Food Associated With Higher Risk of Inflammatory Bowel Disease
July 22nd 2021Because white meat, unprocessed red meat, dairy, starch, fruit, vegetables, and legumes were not associated with the development of IBD, the way that the food is processed may confer this risk of IBD, rather than the food itself.
Read More
Phase 2 Study Indicates Mirikizumab Induces Mucosal Healing in Patients With Ulcerative Colitis
July 12th 2021According to the investigators, gene changes unique among individuals who responded to mirikizumab indicate that mirikizumab affects a distinct molecular healing pathway when compared to the spontaneous healing that occurred among the cohort administered the placebo.
Read More
Upadacitinib Meets Primary Endpoint of Clinical Remission in Patients with Ulcerative Colitis
July 8th 2021Study’s secondary endpoints were also met, including the achievement of endoscopic improvement, histologic-endoscopic mucosal improvement, and corticosteroid-free clinical remission at week 52.
Read More
Study: Healthy Gut Microbiome Responsible for Mucus Layer in the Colon
May 6th 2021According to the authors of the study, the findings could lead to new therapies for inflammatory bowel disease and people who've had portions of their bowels removed due to conditions such as colon cancer and ulcerative colitis.
Read More
Study: Western-Style Diet Promotes Inflammation That Leads to Chronic Diseases
May 5th 2021Processed diets may initially reduce the incidence of foodborne infectious diseases, such as E.coli, but might also increase the incidence of diseases characterized by low-grade chronic infection and inflammation.
Read More
Immune Response From the Gut May Not Provide Systemic Immunity to COVID-19
April 30th 2021If gut-imprinted immune cells are diluted in comparison to immune cells triggered by other parts of the body, there could be implications for the oral-based COVID-19 vaccines currently under development.
Read More
Study: More Belly Weight Increases Danger of Heart Disease Even If BMI Does Not Indicate Obesity
April 27th 2021A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.
Read More